Literature DB >> 12596110

Evaluation of bone mineral density with dual x-ray absorptiometry for osteoporosis in children with bladder augmentation.

Musa Abeş1, Haluk Sarihan, Ercan Madenci.   

Abstract

BACKGROUND/
PURPOSE: Osteoporosis can appear as a result of metabolic acidosis in patients with bladder augmentation and total bladder replacement. These patients must be monitored for early diagnosis and osteoporosis to avoid related complications such as fracture. The current method for diagnosis of osteoporosis mainly involves bone densitometry. Dual x-ray absorptiometry (DXA) provides bone mineral content and bone mineral density (BMD). The purpose of this report is to determine the value of BMD measurement with DXA in the diagnosis and follow-up of osteoporosis and evaluation of response to treatment in the patients with bladder augmentation and total bladder replacement.
METHODS: Six patients with bladder extrophy and neurogenic bladder underwent colocystoplasty, ureterocystoplasty, and total bladder replacement. The Sigmoid colon segment was used for colocystoplasty. DXA (Hologic 2000 DXA) was used for measuring bone mineral content and density. Results for lumbar spinal BMD were expressed as the average of L1 through L4 values. Each patient's BMD was compared with the mean BMD in the young normal population (T score) and in the age- and sex-matched group (Z score). But because our patients were children, BMD was evaluated according to Z score. Arterial blood gas analysis was obtained periodically with BMD measurement. Arterial blood pH and HCO(3) levels of the patients were compared with normal values, which ranged from 7.35 to 7.45 for pH and from 22 to 27 mmol/L for HCO3.
RESULTS: Arterial blood pH of 5 of 6 patients (83.3%) and HCO3 levels of all patients were low. Ten BMD measurements were obtained for 6 children. One patient underwent BMD measurement 3 times, 2 patients underwent twice, and the others once. Z scores of 4 of 6 patients (66.6%) were decreased. Blood pH, HCO3 level, and BMD of 2 patients increased after oral bicarbonate intake. Two patients had normal BMD. One of these patients had ureterocystoplasty. The other had undergone colocystoplasty but was incontinent.
CONCLUSIONS: Intestinal segments have been used for bladder augmentation and total bladder replacement. Exposure of highly absorptive intestinal mucosa to urine has been associated with electrolyte abnormalities and metabolic acidosis. Hyperchloremic acidosis leads to bone demineralization. DXA provides bone mineral content and BMD for diagnosis of osteoporosis. DXA is preferred because the low radiation dose (average, 2 to 4 mrem), accuracy, low price, and short examination time. Not only can BMD confirm the diagnosis of osteoporosis, but it also can be used to monitor the course of the disease and the effectiveness of treatment. Copyright 2003, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12596110     DOI: 10.1053/jpsu.2003.50050

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  4 in total

Review 1.  Osteoporosis in children and adolescents: etiology and management.

Authors:  Giampiero Igli Baroncelli; Silvano Bertelloni; Federica Sodini; Giuseppe Saggese
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

2.  Evaluation of bone mineral density after ileocystoplasty in children with and without myelomeningocele.

Authors:  Ugur Boylu; Kaya Horasanli; Orhan Tanriverdi; Muammer Kendirci; Eyup Gumus; Cengiz Miroglu
Journal:  Pediatr Surg Int       Date:  2006-03-04       Impact factor: 1.827

3.  Exstrophy bladder: Effect of sigmoid colocystoplasty on physical growth and bone mineral density.

Authors:  M Ragavan; N Tandon; V Bhatnagar
Journal:  J Indian Assoc Pediatr Surg       Date:  2011-04

Review 4.  The Impact of Anti-Epileptic Drugs on Growth and Bone Metabolism.

Authors:  Hueng-Chuen Fan; Herng-Shen Lee; Kai-Ping Chang; Yi-Yen Lee; Hsin-Chuan Lai; Pi-Lien Hung; Hsiu-Fen Lee; Ching-Shiang Chi
Journal:  Int J Mol Sci       Date:  2016-08-01       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.